Patents-Review.com
ClassID:

96813 ⎘

C07K14/1825 - CPC Classification

Classification description:

Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses; RNA viruses; Togaviridae; Flaviviridae; Flaviviridae, e.g. pestivirus, mucosal disease virus, bovine viral diarrhoea virus, classical swine fever virus (hog cholera virus), border disease virus Flaviviruses or Group B arboviruses, e.g. yellow fever virus, japanese encephalitis, tick-borne encephalitis, dengue

Recent Application in this class:
#1
20260078403
2026-03-19

ZIKV-BASED GENE DELIVERY SYSTEM

 #2
20260055145
2026-02-26

ANTI-DENGUE VACCINES AND ANTIBODIES

 #3
20250236848
2025-07-24

DEVELOPMENT OF DENGUE VIRUS VACCINE COMPONENTS

 #4
20250018023
2025-01-16

Zika Virus Vaccine

 #5
20250018006
2025-01-16

Compositions and Methods for Dengue Virus Chimeric Constructions in Vaccines

 #6
20240158475
2024-05-16

NS1-BINDING PROTEIN

 #7
20240108712
2024-04-04

Zika virus vaccine

 #8
20240084269
2024-03-14

Development of dengue virus vaccine components

 #9
20230226165
2023-07-20

Zika virus vaccine

 #10
20230181682
2023-06-15

Compositions and methods for dengue virus chimeric constructions in vaccines

 #11
20230149526
2023-05-18

COMBINATIONS OF FLAVIVIRUS PROTEINS, PEPTIDE SEQUENCES, EPITOPES, AND METHODS AND USES THEREOF

 #12
20230129352
2023-04-27

MHC class I associated peptides for prevention and treatment of zika virus

 #13
20230056142
2023-02-23

Virus purification

 #14
20230020362
2023-01-19

INFECTIOUS DISEASE VACCINES

 #15
20230018080
2023-01-19

METHODS AND COMPOSITIONS FOR RECOMBINANT DENGUE VIRUSES OR VACCINE AND DIAGNOSTIC DEVELOPMENT

 #16
20230002452
2023-01-05

TARGETED MOSQUITOCIDAL TOXINS

 #17
20220273786
2022-09-01

Zika virus vaccine

 #18
20220251521
2022-08-11

Development of dengue virus vaccine components

 #19
20220220158
2022-07-14

Method for detecting flavivirus-specific antibodies utilizing flaviviral NS1 polypeptides comprising the wing domain

 #20
20220127307
2022-04-28

ANTI-DENGUE VACCINES AND ANTIBODIES

 #21
20220073875
2022-03-10

Amplifiable RNAs for Therapeutic Cell Systems

 #22
20220062375
2022-03-03

Compositions and methods for dengue virus chimeric constructions in vaccines

 #23
20210355167
2021-11-18

Neutralising antibody against dengue for use in a method of prevention and/or treatment of Zika infection

 #24
20210290749
2021-09-23

Nucleic acids encoding chimeric dengue/Zika viruses optimized for growth and stability in vero cells

 #25
20210269490
2021-09-02

Materials and methods for inhibiting flavivirus infection

 #26
20210188917
2021-06-24

Nucleic acids encoding Zika virus-like particles and their use in Zika virus vaccines and diagnostic assays

 #27
20210093707
2021-04-01

Zika virus purification

 #28
20210054055
2021-02-25

HIGHLY SPECIFIC ZIKA NEUTRALIZING HUMAN ANTIBODIES

 #29
20210009663
2021-01-14

ANTIBODIES THAT BIND ZIKA VIRUS ENVELOPE PROTEIN AND USES THEREOF

 #30
20200384099
2020-12-10

Zika virus vaccine

 #31
20200368344
2020-11-26

CHIKV RNA vaccines

 #32
20200368342
2020-11-26

Virus purification

 #33
20200318083
2020-10-08

Development of dengue virus vaccine components

 #34
20200268871
2020-08-27

MHC class I associated peptides for prevention and treatment of zika virus

 #35
20200255479
2020-08-13

Chimeric reporter West Nile/dengue viruses and their use

 #36
20200230228
2020-07-23

Lentiviral vector-based Japanese encephalitis immunogenic composition

 #37
20200215180
2020-07-09

Glycosylated analogues of Flavivirus E proteins and their use in diagnostic methods

 #38
20200197506
2020-06-25

Virus purification

 #39
20200101150
2020-04-02

Pharmaceutical compositions comprising dengue virus-specific multiple HLA-binding T cell epitopes

 #40
20200061151
2020-02-27

Compositions and Methods for Dengue Virus Chimeric Constructs in Vaccines

 #41
20200048313
2020-02-13

Soluble and immunoreactive flaviviral NS1 polypeptides comprising the wing domain

 #42
20200048312
2020-02-13

Soluble and immunoreactive Zika virus NS1 polypeptides comprising the wing domain

 #43
20190382451
2019-12-19

Zika as a cell penetrating peptide for delivery to the brain

 #44
20190358313
2019-11-28

NEW FLAVIVIRUS VACCINE

 #45
20190330591
2019-10-31

AMPLIFIABLE RNAS FOR THERAPEUTIC CELL SYSTEMS

 #46
20190324040
2019-10-24

ZIKA VIRUS ANTIBODIES

 #47
20190315838
2019-10-17

Antibodies that bind zika virus envelope protein and uses thereof

 #48
20190309025
2019-10-10

Nucleic acids encoding zika virus-like particles and their use in zika virus vaccines and diagnostic assays

 #49
20190300580
2019-10-03

Modified flavivirus envelope sequences comprising unique glycosylation sites

 #50
20190300578
2019-10-03

Dengue virus chimeric polyepitope composed of fragments of non-structural proteins and its use in an immunogenic composition against dengue virus infection

 #51
20190290750
2019-09-26

DNA ANTIBODY CONSTRUCTS FOR USE AGAINST EBOLA VIRUS

 #52
20190256560
2019-08-22

Neutralising antibody against dengue for use in a method of prevention and/or treatment of zika infection

 #53
20190248875
2019-08-15

Zika virus vaccine composition and application thereof

 #54
20190225654
2019-07-25

Methods and compositions for dengue virus vaccines

 #55
20190211065
2019-07-11

HIGH POTENCY IMMUNOGENIC COMPOSITIONS

 #56
20190134184
2019-05-09

Zika viral antigen constructs

 #57
20190119654
2019-04-25

Development of dengue virus vaccine components

 #58
20190060438
2019-02-28

Infectious disease vaccines

 #59
20190031722
2019-01-31

Modified Zika virus NS1 protein with reduced cross-reactive immunogenicity

 #60
20190008945
2019-01-10

Zika virus purification

 #61
20180371027
2018-12-27

Zika virus vaccine

 #62
20180369359
2018-12-27

Virus purification

 #63
20180362937
2018-12-20

Virus purification

 #64
20180362936
2018-12-20

Zika virus purification

 #65
20180327781
2018-11-15

NOVEL RNA-BASED VECTOR SYSTEM FOR TRANSIENT AND STABLE GENE EXPRESSION

 #66
20180325979
2018-11-15

Peptide-induced NK cell activation

 #67
20180312549
2018-11-01

High potency immunogenic zika virus compositions

 #68
20180282757
2018-10-04

Targeted mosquitocidal toxins

 #69
20180193447
2018-07-12

Concomitant dengue and yellow fever vaccination

 #70
20180171308
2018-06-21

Development of dengue virus vaccine components

 #71
20180105583
2018-04-19

Antibodies that bind Zika virus envelope protein and uses thereof

 #72
20180037611
2018-02-08

Anti-dengue vaccines and antibodies

 #73
20170319681
2017-11-09

Lentiviral vector-based Japanese encephalitis immunogenic composition

 #74
20170290884
2017-10-12

Compositions and methods for dengue virus chimeric constructs in vaccines

 #75
20170158740
2017-06-08

Dengue virus chimeric polyepitope composed of fragments of non-structural proteins and its use in an immunogenic composition against dengue virus infection

 #76
20160257719
2016-09-08

Methods and compositions for dengue virus vaccines

 #77
20140127261
2014-05-08

Flavivirus envelope protein mutations affecting virion disassembly

 #78
20130089567
2013-04-11

Development of dengue virus vaccine components

 #79
20130089558
2013-04-11

Dengue and West Nile viruses proteins and genes coding the foregoing, and their use in vaccinal, therapeutic and diagnostic applications

 #80
20130071419
2013-03-21

Universal dengue virus sequences and methods of use

 #81
20130071418
2013-03-21

Physicochemical (PCP) based consensus sequences and uses thereof

 #82
20100104598
2010-04-29

Development of dengue virus vaccine components

 #83
20060073164
2006-04-06

Dengue and West Nile viruses proteins and genes coding the foregoing, and their use in vaccinal, therapeutic and diagnostic applications